Liver transplantation as an alternative for the treatment of perihilar cholangiocarcinoma: A critical review

• Published in: Hepatobiliary & pancreatic diseases international 2024-04, Vol.23 (2), p.139-145
• Main Authors: Andraus, Wellington, Tustumi, Francisco, Santana, Alexandre Chagas, Pinheiro, Rafael Soares Nunes, Waisberg, Daniel Reis, Lopes, Liliana Ducatti, Arantes, Rubens Macedo, Santos, Vinicius Rocha, de Martino, Rodrigo Bronze, D'Albuquerque, Luiz Augusto Carneiro
• Format: Article
• Language: English
• Subjects: Bile Duct Neoplasms - pathology; Bile Ducts, Intrahepatic - surgery; Cholangiocarcinoma; Cholangiocarcinoma - pathology; Hepatectomy - adverse effects; Humans; Klatskin Tumor - pathology; Klatskin Tumor - surgery; Liver neoplasms; Liver transplantation; Liver Transplantation - adverse effects; Retrospective Studies; Treatment Outcome
• ISSN: 1499-3872
• DOI: 10.1016/j.hbpd.2024.01.003

Perihilar cholangiocarcinoma (phCCC) is a dismal malignancy. There is no consensus regarding the best treatment for patients with unresectable phCCC. The present review aimed to gather the current pieces of evidence for liver transplantation and liver resection as a treatment for phCCC and to build better guidance for clinical practice. The search was conducted in PubMed, Embase, Cochrane, and LILACS. The related references were searched manually. Inclusion criteria were: reports in English or Portuguese literature that a) patients with confirmed diagnosis of phCCC; b) patients treated with a curative intent; c) patients with the outcomes of liver resection and liver transplantation. Case reports, reviews, letters, editorials, conference abstracts and papers with full-text unavailability were excluded from the analysis. Most of the current literature is based on observational retrospective studies with low grades of evidence. Liver resection has better long-term outcomes than systemic chemotherapy or palliation therapy and liver transplantation is a good alternative for selected patients with unresectable phCCC. All candidates for resection or transplantation should be medically fit and free of intrahepatic or extrahepatic diseases. As a general rule, patients presenting with a tumor having a longitudinal size > 3 cm or extending below the cystic duct, lymph node disease, confirmed extrahepatic dissemination; intraoperatively diagnosed metastatic disease; a history of other malignancies within the last five years, and did not complete chemoradiation regimen and were medically unfit should not be considered for transplantation. Some of these criteria should be individually assessed. Liver transplantation or resection should only be considered in highly experienced hepatobiliary centers, and any decision-making must be based on a multidisciplinary evaluation. phCCC is a complex condition with high morbidity. Surgical therapies, including hepatectomy and liver transplantation, are the best option for better long-term disease-free survival.